Harvard Bioscience (HBIO) Shares Outstanding (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Shares Outstanding data on file, last reported at $4.5 million in Q1 2026.

• Quarterly Shares Outstanding rose 2.02% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (up 2.02% YoY) and the FY2025 annual result came in at $4.5 million, up 1.47% from the prior year.
• Shares Outstanding climbed to $4.5 million in Q1 2026 per HBIO's latest filing, from $4.5 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $44.6 million in Q3 2025 and bottomed at $4.4 million in Q4 2024.
• The 5-year median for Shares Outstanding is $42.2 million (2023), against an average of $33.8 million.
• The widest annual swing landed in 2023, when Shares Outstanding grew 3.12%; it then tumbled 89.84% in 2024.
• Tracing HBIO's Shares Outstanding over 5 years: stood at $42.1 million in 2022, then gained by 3.12% to $43.4 million in 2023, then plunged by 89.84% to $4.4 million in 2024, then increased by 1.47% to $4.5 million in 2025, then rose by 0.85% to $4.5 million in 2026.
• Per Business Quant, the three latest HBIO Shares Outstanding figures stand at $4.5 million (Q1 2026), $4.5 million (Q4 2025), and $44.6 million (Q3 2025).

Peer Comparison